stars 1 stars 2 stars 3

Elypta is a Swedish diagnostic company focused on developing new biomarkers for cancer risk-stratification. The company pursues profiling of glycosaminoglycans (GAGome) as a new category of dynamic biological risk markers with the aim to enable an expansion of cancer screening and prevention. Elypta’s leading indication is lung cancer risk with a broader program targeting multi-cancer risk applications. Elypta also serves the glycosaminoglycan research community with standardized GAGome quantification kits for research use.

Elypta Questions

Karl Bergman is the CEO of Elypta.

18 people are employed at Elypta.

Elypta is based in Solna, Stockholm County.

Top Elypta Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users